Retinal Venular Vasculature May Predict Initial Treatment Response To Intravitreal Therapy
- byDoctor News Daily Team
- 02 August, 2025
- 0 Comments
- 0 Mins
Denmark: A research article published in Acta Ophthalmologica, a study has demonstrated that retinal venular vasculature may predict the initial treatment response to intravitreal therapy. If the visual and functional prognosis of nAMD patients can be categorized before initiating treatment, then it is possible to provide a personalized treatment regimen.
Prediction of the early treatment response is crucial in neovascular age-related macular degeneration (nAMD).
Researchers in the present study tested whether non-invasive measurements of the retinal vascular structure predict initial intravitreal treatment outcomes.
They included 58 eyes (58 patients) with treatment-naïve nAMD. Using Singapore I Vessel Assessment, they measured advanced markers of the retinal vascular structure before starting intravitreal treatment, which included three monthly injections of aflibercept.
They categorized the patients as full treatment responders (FTR) or non/partial treatment responders (N/PR).
The results of this research article are summarised below:
In 54 eyes with follow-up, 44.4% were categorized as FTR. These patients were older (81.5 vs 77 years and before treatment, their eyes had a lower retinal arteriolar fractal dimension (Fd) (1.21 vs 1.24 units) and venular length-diameter ratio (LDR) (7.3 vs 15.9 units).
These did not differ regarding other retinal vascular parameters.
A higher retinal venular LDR independently predicted a lower chance of FTR and marginally by a higher retinal arteriolar Fd.
They said, “Retinal venular LDR independently predicted the initial treatment response in nAMD. This can guide treatment If confirmed by long-term studies.
The study strengths include prospective design, validated retinal structural measurements, and the inclusion of a treatment-naïve cohort.
The limitations include a limited number of patients and a lack of data on the subtypes of macular neovascularization, so we recommend more long-term studies to determine precision and validity.
Further reading:
Leth-Møller Christensen K, Kristjansen DB, Vergmann AS, Torp TL, Peto T, Grauslund J. Retinal vascular structure independently predicts the initial treatment response in neovascular age-related macular degeneration. Acta Ophthalmol. 2023 May 17. doi: 10.1111/aos.15709.
Disclaimer: This website is designed for healthcare professionals and serves solely for informational purposes.
The content provided should not be interpreted as medical advice, diagnosis, treatment recommendations, prescriptions, or endorsements of specific medical practices. It is not a replacement for professional medical consultation or the expertise of a licensed healthcare provider.
Given the ever-evolving nature of medical science, we strive to keep our information accurate and up to date. However, we do not guarantee the completeness or accuracy of the content.
If you come across any inconsistencies, please reach out to us at
admin@doctornewsdaily.com.
We do not support or endorse medical opinions, treatments, or recommendations that contradict the advice of qualified healthcare professionals.
By using this website, you agree to our
Terms of Use,
Privacy Policy, and
Advertisement Policy.
For further details, please review our
Full Disclaimer.
Recent News
Pfizer files lawsuit against Metsera, its Director...
- 02 November, 2025
Health Ministry achieves 3 Guinness World Records...
- 02 November, 2025
Roche gets CE mark for Elecsys Dengue Ag test to d...
- 02 November, 2025
Daily Newsletter
Get all the top stories from Blogs to keep track.
0 Comments
Post a comment
No comments yet. Be the first to comment!